We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · January 06, 2022

Transcriptomic Characterization of Prurigo Nodularis and the Response to Nemolizumab

Journal of Allergy and Clinical Immunology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Allergy and Clinical Immunology
Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab
J. Allergy Clin. Immunol 2021 Nov 09;[EPub Ahead of Print], LC Tsoi, F Hacini-Rachinel, P Fogel, F Rousseau, X Xing, MT Patrick, AC Billi, CC Berthier, JM Kahlenberg, A Lazzari, H Wiegmann, S Ständer, C Piketty, V Julia, JK Krishnaswamy, JE Gudjonsson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading